N-[(1S,2R,3S,4R)-4-[2-[(3R)-3-(3,4-dihydro-2H-1,5-benzodioxepin-7-ylcarbamoylamino)pyrrolidin-1-yl]-6-(2,2-diphenylethylamino)purin-9-yl]-2,3-dihydroxycyclopentyl]-2,2,2-trifluoro-N-propylacetamide

C43H48F3N9O6 — CID 87083222

IUPACN-[(1S,2R,3S,4R)-4-[2-[(3R)-3-(3,4-dihydro-2H-1,5-benzodioxepin-7-ylcarbamoylamino)pyrrolidin-1-yl]-6-(2,2-diphenylethylamino)purin-9-yl]-2,3-dihydroxycyclopentyl]-2,2,2-trifluoro-N-propylacetamide
SMILESCCCN(C(=O)C(F)(F)F)[C@H]1C[C@@H](n2cnc3c(NCC(c4ccccc4)c4ccccc4)nc(N4CC[C@@H](NC(=O)Nc5ccc6c(c5)OCCCO6)C4)nc32)[C@H](O)[C@@H]1O
InChIInChI=1S/C43H48F3N9O6/c1-2-17-54(40(58)43(44,45)46)31-22-32(37(57)36(31)56)55-25-48-35-38(47-23-30(26-10-5-3-6-11-26)27-12-7-4-8-13-27)51-41(52-39(35)55)53-18-16-29(24-53)50-42(59)49-28-14-15-33-34(21-28)61-20-9-19-60-33/h3-8,10-15,21,25,29-32,36-37,56-57H,2,9,16-20,22-24H2,1H3,(H,47,51,52)(H2,49,50,59)/t29-,31+,32-,36-,37+/m1/s1
InChIKeyQGSYQPMOXSRVKV-SXGGEUIESA-N
MW843.91 g/mol
LogP5.47
Rot. Bonds12

About N-[(1S,2R,3S,4R)-4-[2-[(3R)-3-(3,4-dihydro-2H-1,5-benzodioxepin-7-ylcarbamoylamino)pyrrolidin-1-yl]-6-(2,2-diphenylethylamino)purin-9-yl]-2,3-dihydroxycyclopentyl]-2,2,2-trifluoro-N-propylacetamide

N-[(1S,2R,3S,4R)-4-[2-[(3R)-3-(3,4-dihydro-2H-1,5-benzodioxepin-7-ylcarbamoylamino)pyrrolidin-1-yl]-6-(2,2-diphenylethylamino)purin-9-yl]-2,3-dihydroxycyclopentyl]-2,2,2-trifluoro-N-propylacetamide (PubChem CID 87083222) has the molecular formula C43H48F3N9O6 and a molecular weight of 843.91 g/mol. Its IUPAC name is N-[(1S,2R,3S,4R)-4-[2-[(3R)-3-(3,4-dihydro-2H-1,5-benzodioxepin-7-ylcarbamoylamino)pyrrolidin-1-yl]-6-(2,2-diphenylethylamino)purin-9-yl]-2,3-dihydroxycyclopentyl]-2,2,2-trifluoro-N-propylacetamide.

Molecular Properties

Compound NameN-[(1S,2R,3S,4R)-4-[2-[(3R)-3-(3,4-dihydro-2H-1,5-benzodioxepin-7-ylcarbamoylamino)pyrrolidin-1-yl]-6-(2,2-diphenylethylamino)purin-9-yl]-2,3-dihydroxycyclopentyl]-2,2,2-trifluoro-N-propylacetamide
PubChem CID87083222
Molecular FormulaC43H48F3N9O6
Molecular Weight843.91 g/mol
Exact Mass843.37
IUPAC NameN-[(1S,2R,3S,4R)-4-[2-[(3R)-3-(3,4-dihydro-2H-1,5-benzodioxepin-7-ylcarbamoylamino)pyrrolidin-1-yl]-6-(2,2-diphenylethylamino)purin-9-yl]-2,3-dihydroxycyclopentyl]-2,2,2-trifluoro-N-propylacetamide
SMILESCCCN(C(=O)C(F)(F)F)[C@H]1C[C@@H](n2cnc3c(NCC(c4ccccc4)c4ccccc4)nc(N4CC[C@@H](NC(=O)Nc5ccc6c(c5)OCCCO6)C4)nc32)[C@H](O)[C@@H]1O
InChIInChI=1S/C43H48F3N9O6/c1-2-17-54(40(58)43(44,45)46)31-22-32(37(57)36(31)56)55-25-48-35-38(47-23-30(26-10-5-3-6-11-26)27-12-7-4-8-13-27)51-41(52-39(35)55)53-18-16-29(24-53)50-42(59)49-28-14-15-33-34(21-28)61-20-9-19-60-33/h3-8,10-15,21,25,29-32,36-37,56-57H,2,9,16-20,22-24H2,1H3,(H,47,51,52)(H2,49,50,59)/t29-,31+,32-,36-,37+/m1/s1
InChIKeyQGSYQPMOXSRVKV-SXGGEUIESA-N
XLogP5.47
TPSA179.23 Ų
H-Bond Donors5
H-Bond Acceptors12
Rotatable Bonds12
Heavy Atoms61
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500843.91
LogP ≤ 55.47
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1012

Analyze N-[(1S,2R,3S,4R)-4-[2-[(3R)-3-(3,4-dihydro-2H-1,5-benzodioxepin-7-ylcarbamoylamino)pyrrolidin-1-yl]-6-(2,2-diphenylethylamino)purin-9-yl]-2,3-dihydroxycyclopentyl]-2,2,2-trifluoro-N-propylacetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[(1S,2R,3S,4R)-4-[2-[(3R)-3-(3,4-dihydro-2H-1,5-benzodioxepin-7-ylcarbamoylamino)pyrrolidin-1-yl]-6-(2,2-diphenylethylamino)purin-9-yl]-2,3-dihydroxycyclopentyl]-2,2,2-trifluoro-N-propylacetamide?
The IUPAC name of N-[(1S,2R,3S,4R)-4-[2-[(3R)-3-(3,4-dihydro-2H-1,5-benzodioxepin-7-ylcarbamoylamino)pyrrolidin-1-yl]-6-(2,2-diphenylethylamino)purin-9-yl]-2,3-dihydroxycyclopentyl]-2,2,2-trifluoro-N-propylacetamide (CID 87083222) is N-[(1S,2R,3S,4R)-4-[2-[(3R)-3-(3,4-dihydro-2H-1,5-benzodioxepin-7-ylcarbamoylamino)pyrrolidin-1-yl]-6-(2,2-diphenylethylamino)purin-9-yl]-2,3-dihydroxycyclopentyl]-2,2,2-trifluoro-N-propylacetamide.
What is the SMILES notation for N-[(1S,2R,3S,4R)-4-[2-[(3R)-3-(3,4-dihydro-2H-1,5-benzodioxepin-7-ylcarbamoylamino)pyrrolidin-1-yl]-6-(2,2-diphenylethylamino)purin-9-yl]-2,3-dihydroxycyclopentyl]-2,2,2-trifluoro-N-propylacetamide?
The canonical SMILES for N-[(1S,2R,3S,4R)-4-[2-[(3R)-3-(3,4-dihydro-2H-1,5-benzodioxepin-7-ylcarbamoylamino)pyrrolidin-1-yl]-6-(2,2-diphenylethylamino)purin-9-yl]-2,3-dihydroxycyclopentyl]-2,2,2-trifluoro-N-propylacetamide is CCCN(C(=O)C(F)(F)F)[C@H]1C[C@@H](n2cnc3c(NCC(c4ccccc4)c4ccccc4)nc(N4CC[C@@H](NC(=O)Nc5ccc6c(c5)OCCCO6)C4)nc32)[C@H](O)[C@@H]1O.
What is the InChIKey of N-[(1S,2R,3S,4R)-4-[2-[(3R)-3-(3,4-dihydro-2H-1,5-benzodioxepin-7-ylcarbamoylamino)pyrrolidin-1-yl]-6-(2,2-diphenylethylamino)purin-9-yl]-2,3-dihydroxycyclopentyl]-2,2,2-trifluoro-N-propylacetamide?
The InChIKey is QGSYQPMOXSRVKV-SXGGEUIESA-N. The full InChI is InChI=1S/C43H48F3N9O6/c1-2-17-54(40(58)43(44,45)46)31-22-32(37(57)36(31)56)55-25-48-35-38(47-23-30(26-10-5-3-6-11-26)27-12-7-4-8-13-27)51-41(52-39(35)55)53-18-16-29(24-53)50-42(59)49-28-14-15-33-34(21-28)61-20-9-19-60-33/h3-8,10-15,21,25,29-32,36-37,56-57H,2,9,16-20,22-24H2,1H3,(H,47,51,52)(H2,49,50,59)/t29-,31+,32-,36-,37+/m1/s1.
What are the key properties of N-[(1S,2R,3S,4R)-4-[2-[(3R)-3-(3,4-dihydro-2H-1,5-benzodioxepin-7-ylcarbamoylamino)pyrrolidin-1-yl]-6-(2,2-diphenylethylamino)purin-9-yl]-2,3-dihydroxycyclopentyl]-2,2,2-trifluoro-N-propylacetamide?
N-[(1S,2R,3S,4R)-4-[2-[(3R)-3-(3,4-dihydro-2H-1,5-benzodioxepin-7-ylcarbamoylamino)pyrrolidin-1-yl]-6-(2,2-diphenylethylamino)purin-9-yl]-2,3-dihydroxycyclopentyl]-2,2,2-trifluoro-N-propylacetamide has a molecular weight of 843.91 g/mol, XLogP of 5.47, 12 rotatable bonds, 5 hydrogen bond donors, and 12 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(1S,2R,3S,4R)-4-[2-[(3R)-3-(3,4-dihydro-2H-1,5-benzodioxepin-7-ylcarbamoylamino)pyrrolidin-1-yl]-6-(2,2-diphenylethylamino)purin-9-yl]-2,3-dihydroxycyclopentyl]-2,2,2-trifluoro-N-propylacetamide is sourced from PubChem (CID 87083222), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).